US Stock MarketDetailed Quotes

DK Delek US

Watchlist

28.970
-0.330-1.13%

Trading Apr 26 10:34 ET

1.85BMarket Cap96.57P/E (TTM)

Delek US Stock Forum

Moomoo AI

Feb 23 23:14

Delek US Holdings' low P/S ratio is due to predicted revenue decline. Investors see no significant potential for revenue growth to justify a higher P/S ratio. Without major changes, a significant stock price increase is unlikely. The company's weak outlook is pressuring the shares downwards.

Benign Growth For Delek US Holdings, Inc. (NYSE:DK) Underpins Its Share Price

Moomoo AI

Jan 19 05:56

The board of Delek US Holdings expresses positive sentiment towards the appointment of Ms. Benson, highlighting her experience in risk management, capital markets, and green energies as instrumental for the company's strategic initiatives.

Press Release: Delek US Holdings Board Appoints New Director

Moomoo AI

Nov 15, 2023 20:51

Delek's lower Return on Equity (ROE) coupled with high debt levels make it less attractive for investment. Investors should also consider profit growth rates and market expectations before investing in Delek or similar companies.

Should We Be Cautious About Delek US Holdings, Inc.'s (NYSE:DK) ROE Of 8.4%?

Moomoo Breakfast US

Jun 22, 2022 20:48

ColumnsToday's pre-market stock movers: BBIO, LZB, ORA, DOW and more

Gainers:
• $La-Z-Boy(LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals(ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer(PFE.US)$)
• $Ikena Oncology(IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma(BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech(KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...